English Українська
  • Main
  • Useful links
  • Information for Contributors
  • About
  • Editorial board

  • Article
    Fushtey I. M., Tokarenko O. O.

    LEFT VENTRICULAR STRUCTURAL AND FUNCTIONAL ALTERATIONS IN PATIENTS WITH STAGE II ESSENTIAL HYPERTENSION


    About the author: Fushtey I. M., Tokarenko O. O.
    Heading CLINICAL MEDICINE
    Type of article Scentific article
    Annotation Arterial hypertension (AH) causes both remodeling of left ventricular (LV) and worsening of renal function, therefore studying the relationship between cardiac and renal pathology in this aspect is very important. The aim was to identify the characteristics of intracardiac hemodynamics and remodeling of LV in patients with essential hypertension (EH) II stage complicated by nephropathy. There were examined two groups of patients with EH stage II of the second (n=31) and third (n=31) degree of AH with nephropathy, as well as three comparison groups, including patients with EH stage II of the second (n=31) and third (n=31) degree of AH without nephropathy and practically healthy persons (n=31). The ratio value of albumin/creatinine content in urine ≥ 30 mg/d was regarded as a marker of kidney disorder. Echocardiographic study was conducted by conventional methods. It was revealed that in patients with EH stage II of the second and third degree hypertension and nephropathy there are significant changes of the morphometric and volumetric parameters of the LV. In patients with EH stage II and nephropathy significantly greater changes of left ventricular transmitral blood flow are manifested comparing with patients with EH stage II without nephropathy. There was detected a significant increase of pathological LV geometry types with prevalence of concentric remodeling and concentric hypertrophy in patients with EH stage II and nephropathy in comparison with patients with EH stage II without nephropathy.
    Tags hypertensive nephropathy, left ventricular geometry types, cardiac remodeling, diastolic dysfunction
    Bibliography
    • Muhin N. A. Albuminuriya – marker porazheniya pochek i riska serdechno-sosudistyih oslozhneniy / N.A. Muhin, G.P. Arutyunov, V.V. Fomin // Klinicheskaya nefrologiya. – 2009. – No. 1. – S. 5 – 10.
    • Sirenko Yu. M. Arterialna gipertenziya ta suputnya patologiya / Yu. M. Sirenko // – Donetsk - 2010. – 384 s.
    • Andrikou E. Left ventricular mass index as a predictor of new-onset microalbuminuria in hypertensive subjects: a prospective study / E. Andrikou, C. Tsioufis, C. Thomopoulos [et al.] // American Journal of Hypertension. – 2012. – Vol. 25(11). – P. 1195 – 1201.
    • Lang R. M. ESC 2013: Lang R.M. Recommendations for chamber quantification / R. M. Lang, M. Bierig, R.B. Devereux [et al.] // European journal of echocardiography. – 2006. – Vol.7. – P. 79 – 108.
    • Monfared A. Left ventricular hypertrophy and microalbuminuria in patients with essential hypertension / A. Monfared, A. Salari, F. Mirbolok [et al.] // Iranian Journal of Kidney Diseases. – 2013. – Vol. 7(3) . – P. 192 – 197.
    • Peng T. Correlation between endothelial dysfunction and left ventricular remodeling in patients with chronic kidney disease. / T. Peng, Z. Hu, L. Wu [et al.] // Kidney & Blood Pressure Research. – 2014. – Vol. 39(5). – P. 420 – 426.
    • Rodilla E. Regression of left ventricular hypertrophy and microalbuminuria changes during antihypertensive treatment / E. Rodilla, J.M. Pascual, J.A. Costa [et al.] // Journal of Hypertension. – 2013. – № 31(8). – P. 1683 – 1691.
    • Viazzi F. Combined effect of albuminuria and estimated glomerular filtration rate on cardiovascular events and all-cause mortality in uncomplicated hypertensive patients / F. Viazzi, G. Leoncini, N. Conti [et al.] // Journal of Hypertension. – 2010. – Vol. 28(4). – P. 848 – 855.
    Publication of the article «World of Medicine and Biology» №3(52) 2 part 2015 year, 048-053 pages, index UDK 616.61:616.12-008.331.1:616.127-073.432.19